多囊卵巢综合征患者血清核因子-κB和转化生长因子β1的表达及其与胰岛素抵抗的相关性研究被引量：16

Serum Nuclear Factor-κB and Transforming Growth Factor-a1 and Those Relationship with Insulin Resistance in Polycystic Ovary Syndrome

原文传递

导出

摘要目的:探讨多囊卵巢综合征(PCOS)患者血清中核因子-κB(NF-κB)、转化生长因子β1(TGF-β1)的表达,及NF-κB、TGF-β1与胰岛素抵抗(IR)的相关性。方法:收集108例PCOS患者作为PCOS组,47例正常女性作为对照组,根据体质量指数(BMI)将其分为肥胖组(BMI≥28 kg/m2)与非肥胖组(BMI<28 kg/m2),根据胰岛素抵抗指数(HOMA-IR)将PCOS患者分为IR组(HOMA-IR≥2.69)及非IR组(HOMA-IR<2.69);应用酶联免疫法测量受试者血清中NF-κB、TGF-β1水平,同时对入组患者进行葡萄糖耐量(OGTT)及胰岛素释放(IRT)测定。结果:①PCOS患者血清中NF-κB、TGF-β1明显高于对照组(P<0.05),PCOS-IR组NF-κB、TGF-β1明显高于PCOS非IR组(P<0.05);②Pearson相关分析显示,NF-κB、TGF-β1与PCOS患者的雄激素(T)水平、BMI、HOMA-IR呈正相关(P<0.05)。结论:NF-κB、TGF-β1与PCOS患者T水平、IR密切相关,TGF-β1与NF-κB亦呈正相关,NF-κB、TGF-β1与PCOS密切相关。 Objective： To study the expression of serum nuclear factor-kB （NF-kB） and transforming growth factor-f3 I（TGF-β1） in polycystic ovary syndrome （PCOS） patient and analyze the correlation among insulin resistance （IR）, NF-kB and TGF-β 1. Methods： A total of 108 female patients with PCOS were recruited as PCOS group and compared with 47 healthy women from control group. Participants were divided into two groups based on body mass index （BMI）, BMI ≥ 28 kg/m2 was considered as the obese group, BMI〈28 kg/m2 was considered as the non-obese group; PCOS women were divided into two groups using the criterion of HOMA-IR≥ 2.69 as IR group and HOMA-IR〈2.69 as non-IR group. Serum NF-kB and TGF-β1 levels were measured using euzymelinked immunosorbent assay （ELISA）. Oral glucose tolerance test （OGTT） and insulin sensitivity were also assessed in the selected people. Results： 1） The PCOS group presented significantly higher serum NF-kB and TGF-β1 than those in the control （P〈0.05）, while the two factors are obviously higher in PCOS-IR group than in PCOS-non-IR group （P〈0.05）. 2） Pearson analysis revealed that NF-kB and TGF-β1 of the PCOS group had a positive correlation with HOMA-IR, BMI and testosterone （T） level （P〈0.05）. Conclusion： NF- kB is also positively correlated with TGF-β1, while they have a strong link with IR and T level in women with PCOS.

作者任小胖刘梅梅陈亮陈天也张艳华李佩玲刘丽原振宇

机构地区哈尔滨医科大学哈尔滨医科大学附属第二医院妇产科

出处《生殖与避孕》 CAS CSCD 2013年第8期529-533,545,共6页 Reproduction and Contraception

基金黑龙江省教育厅资助项目,项目编号:12511201

关键词多囊卵巢综合征(PCOS) 核因子-κB(NF-κB) 转化生长因子β1(TGF-β1) 胰岛素抵抗(IR) 慢性炎症 polycystic ovary syndrome （PCOS） nuclear factor-K/3 （NF-kB） transforming growth factor-β1（TGF-β1） insulin resistance （IR） chronic inflammation

分类号 R711.75 [医药卫生—妇产科学]

引文网络
相关文献

参考文献21

1Legro RS, Gnatuk CL, Kunselman AR, et al. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. Clin Endocrinol Metab, 2005, 90(6):3236-42.
2Wild S, Pierpoint T, McKeigue P, et al. Cardiovascular disease in women with polycystic ovary syndrome at longterm fol- low-up: a retrospective cohort study. Clin Endocrinol (Oxf), 2000, 52(5):595-600.
3Niwa K, Imai A, Hashimoto M, et al. A case-control study of uterine endometrial cancer of pre- and post-meno- pausal women. Dncol Rep, 2000, 7(1):89-93.
4Tarktm I, Arslan BC, Canturh Z, et al. Endothelial dysfunction in young women with polycystic ovary syndrome: relation- ship with insulin resistance and low-grade chronic inflammation. Chin Endocrinol Metab, 2004, 89(11):5592-6.
5Blum CA, Muller B, Huber P, et al. Low-grade inflammation and estimates of insulin resistance during and menstrui cycle in lean and overweight women. J Chin Endocrinol Metab, 2005, 90(6):3230-5.
6Lan W, Petznick A, Heryati S, et al. Nuclear factor-rd3: central regulator in ocular surface inflammation and diseases. Ocul Surf, 2012, 10(3):137-48.
7Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci, 2004, 29 (2):72-9.
8De Lsxco JE, Todaro GJ. Growth factors from routine sarcoma virus transformed cells. Proc Nail Acad Sci USA, 1978, 75(8): 4001-5.
9Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril, 2004, 81(1): 19-25.
10Sen R, Baltimore D. Multiple nuclear factor interact with the immunoglobulin enhancer sequence. Cell, 1986, 46(5): 705-16.

二级参考文献14

1张宁,石玉华,陈子江.多囊卵巢综合征胰岛素抵抗相关基因研究进展[J].生殖与避孕,2006,26(8):491-495. 被引量：5
2Yudkin JS,Stehowver CD,Emeis JJ,et al.C-reactive protein in healthy subjects:associations with obesity,insulin resistance,and endothelial dysfunction:a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol,1999,19(4):972-8.
3Festa A,D'Agostino R Jr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance syndrome:the insulin resistance atherosclerosis study(IRAS).Circulation,2000,102(7):42-7.
4The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS).Hum Reprod,2004,19(1):41-7.
5Haffner SM,Miettinen H,Stem MP.The homeostasis model in the San Antonio heart study.Diabetes Care,1997,20(7):1 087-93.
6Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.Nat Med,2001,7(8):941-6.
7Yamauchi T,Kamon J,Waki H,et al.Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.J Biol Chem,2003,278(4):2 461-8.
8Manigrasso MR,Ferroni P,Santilli F,et al.Association between circulating adiponectin and inerleukin-10 levels in android obesity:effects of weight loss.J Clin Endocrinol Metab,2005,90(10):5 876-9.
9Wolf AM,Wolf D,Rumpold H,et al.Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.Biochem Biophys Res Common,2004,323(2):630-5.
10Ajuwon KM,Spurlock ME.Adiponectin inhibits LPS-induced NF-kappaB activiation and IL-6 production,and increases PPAR-2 expression in adipocytes.Am J Physiol Regul Integr Comp Physiol,2004,288(5):R1 220-5.